Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells

Liu,Wen‑Xin; Liu,Xiang‑Yu; Yu,Hu; Chen,Ying; Hao,Quan

doi:10.3892/mmr.2014.2980

March-2015 Volume 11 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2015 Volume 11 Issue 3

Full Size Image

Article Open Access

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells

Authors:
- Wen‑Xin Liu
- Xiang‑Yu Liu
- Hu Yu
- Ying Chen
- Quan Hao
View Affiliations / Copyright

Affiliations: Department of Gynecologic Neoplasms, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China

Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
Pages: 1745-1751
|
Published online on: November 19, 2014

https://doi.org/10.3892/mmr.2014.2980
Expand metrics +

Abstract

The aim of the present study was to determine the effect of cyclin‑dependent kinase 7 (CDK7) silencing on the sensitivity of the HEC‑1‑A endometrial carcinoma cell line to cisplatin [cis‑dichlorodiammineplatinum (II), or DDP]. Four CDK7 siRNA fragments were designed and synthesized based on the gene sequence of CDK7 and transfected into HEC‑1‑A cells. The RNA interference of the fragments was confirmed by semi‑quantitative polymerase chain reaction (PCR) and western blot analyses. The CDK7‑423 siRNA fragment exhibited the most marked silencing of CDK‑7 (>70%), and was chosen for the subsequent experiments in HEC‑1‑A endometrial carcinoma cells. The sensitivity of the cells to a chemotherapeutic agent (cisplatin) was determined before and after transfection of the siRNA, using a MTT cytotoxicity assay, flow cytometry and Hoechst/propidium iodide (PI) double‑staining immunofluorescence microscopy. The results of the MTT cytotoxicity assay showed that the half maximal inhibitory concentration of cisplatin was reduced from 45.12 µg/ml to 3.200 µg/ml following the inhibition of CDK7 expression levels, indicating a significantly increased cytotoxicity in the treated cells (P<0.05). The flow cytometry analysis showed that the mean rate of apoptosis in the CDK7 low‑expression group was 37.57%, which was significantly higher than the rate in the parental cells (11.66%) (P<0.05). Hoechst/PI co‑immunofluorescence microscopy revealed that the number of apoptotic bodies in the CDK7 low‑expression HEC‑1‑A cells was significantly increased as compared with the parental cells. Downregulation of CDK7 expression levels in HEC‑1‑A endometrial carcinoma cells via the transfection of CDK7 siRNA may significantly enhance cancer cell sensitivity to cisplatin chemotherapy and increasing apoptosis. CDK7 is a novel promising treatment for endometrial carcinoma that requires further in‑depth study.

View Figures

View References

1	Moxley KM and McMeekin DS: Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents. Oncologist. 15:1026–1033. 2010. View Article : Google Scholar : PubMed/NCBI
2	Wen-Xin L and Xi-Shan H: Application of laser capture microdissection and differential display technique for screening of pathogenic genes involved in endometrial carcinoma. Int J Gynecol Cancer. 17:1224–1230. 2007. View Article : Google Scholar : PubMed/NCBI
3	Liu WX and Hao XS: Screening, cloning and identification of the human endometrial carcinoma-related genes. Zhonghua Zhong Liu Za Zhi. 29:584–588. 2007.(In Chinese).
4	Liu WX, Liu YX and Chen Y: Expression and significance of CDK7 and CyclinH in endometrial carcinoma. Shandong Medical Journal. 51:74–75. 2011.(In Chinese).
5	Zhan SS, Yuan W and Cai JY: Dependent kinase activation cell cycle protein kinase and tumor. China Practical Medicine. 5:243–244. 2010.
6	Suryadinata R, Sadowski M and Sarcevic B: Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates. Biosci Rep. 30:243–255. 2010. View Article : Google Scholar : PubMed/NCBI
7	Zhovmer A, Oksenych V and Coin F: Two sides of the same coin: TFIIH complexes in transcription and DNA repair. Scientific World Journal. 13:633–643. 2010. View Article : Google Scholar
8	Zhao AG and Wu SG: Silence CDK7 and CDK2 leads to phosphorylation of pRb and induces apoptosis in HepG2 cells decreased. Chinese Pharmacological Bulletin. 21:106–110. 2005.(In Chinese).
9	Tong WG, Chen R, Plunkett W, Siegel D, Sinha R, Harvey RD, Badros AZ, Popplewell L, Coutre S, Fox JA, et al: Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma. J Clin Oncol. 28:3015–3022. 2010. View Article : Google Scholar : PubMed/NCBI
10	Boquoi A, Chen T and Enders GH: Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032. Cancer Prev Res. 2:800–806. 2009. View Article : Google Scholar
11	Walsby E, Lazenby M, Pepper C and Burnett AK: The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine. Leukemia. 25:411–419. 2011. View Article : Google Scholar : PubMed/NCBI
12	Dickson MA and Schwartz GK: Development of cell-cycle inhibitors for cancer therapy. Curr Oncol. 16:36–43. 2009.PubMed/NCBI
13	Liu T, Sun MT, Dong XW, Ren X, Yang X, Du LL and Hu YZ: Structure-Based Drug Design, Synthesis and Antitumor Activities of Novel CDK7 Inhibitors. Acta Phys Chim Sin. 25:2107–2112. 2009.(In Chinese).
14	Moxley KM and McMeekin DS: Endometrial carcinoma: a review of chemotherapy, drug resistance, and the search for new agents. Oncologist. 15:1026–1033. 2010. View Article : Google Scholar : PubMed/NCBI
15	Humber CE, Tiemey JF, Symonds RP, et al: Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol. 18:409–420. 2007. View Article : Google Scholar
16	Shen XY and Xiang Y: Endometrial cancer chemotherapy. International Journal of Obstetrics and Gynecology. 37:436–439. 2010.
17	Yang HZ: Cisplatin resistance lung adenocarcinoma cancer screening of differentially expressed genes and functional. unpublished PhD thesis. Central South University; 2007

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles